Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2001085917A3 A device
10/09/2003WO2001071027A3 mRNA AMPLIFICATION
10/09/2003US20030192078 Modifying a wild-type structural gene sequence encoding an insecticidal protein of Bacillus thuringiensis to enhance the expression of protein in plants by removing polyadenylation signals and retaining a sequence which codes such protein
10/09/2003US20030192075 Elicitor from cladosporium
10/09/2003US20030192071 Isolated and purified nucleic acids comprising a gene and a regulatory region for the gene expression of the same
10/09/2003US20030192069 Glycerol kinase gene disruptions, compositions and methods related thereto
10/09/2003US20030192064 Transcription enhancers such as serine protease inhibitor-growth hormone responsive element
10/09/2003US20030191300 Antisense modulation of bcl-x expression
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030191077 Method and reagent for the treatment of asthma and allergic conditions
10/09/2003US20030191073 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030191059 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders
10/09/2003US20030190752 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof
10/09/2003US20030190751 Directed switch-mediated DNA recombination
10/09/2003US20030190749 Expression element that comprises a gene linked to sequences that are inducible and/or repressible; mutations; useful in diagnositics, therapeutics and drug discovery
10/09/2003US20030190748 In the presence of fibroblast growth factor; allows stable prolifertion and differentiation while maintaining karyotype
10/09/2003US20030190747 Method of preparing culture support factor from insects
10/09/2003US20030190746 Gene expression control system and its use in recombinant virus packaging cell lines
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
10/09/2003US20030190734 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190704 Methods and compositions for anchoring stem cells in a microenvironment
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190683 Minicell-based rational drug design
10/09/2003US20030190682 Preparation of immunostimulatory vaccines with activated antigen presenting cells which stimulate a therapeutic T cells response in vivo; used to treat cancer
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190659 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases
10/09/2003US20030190654 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190648 Involves extraction of a partial sequence corresponding to a target gene from a genome sequence by homology search on a database, prediction and extraction of common sequences from exon regions using plural programs, amplification
10/09/2003US20030190643 Sequencing by mass spectrometry
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190638 Determination of telomere length and telomerase activity, ability to increase/decrease the activity in treatment of proliferative diseases; intracellular inhibition of telomerase activity; treatment of cancer and AIDS, muscular dystrophy
10/09/2003US20030190631 Predicting an increased risk of a human developing Alzheimer's disease by assaying for a mutation within the ADN sequence of the CP2/LSF/ LBP-1 gene
10/09/2003US20030190629 Antisense modulation of PTTG1 expression
10/09/2003US20030190626 Having increased nuclease resistance and binding affinity to a complementary strand of nucleic acid; useful for modulating expression of a protein in organisms, for diagnosis, therapy of conditions responsive to oligonucleotide therapeutics
10/09/2003US20030190617 Can be used to diagnose, prognose, and treat glaucoma and related disorders
10/09/2003US20030190614 Non-human primate Fc receptors and methods of use
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190601 Useful for diagnosis and therapy, research tools for drug discovery
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190306 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/09/2003CA2762016A1 Methods for increasing polypeptide production
10/09/2003CA2488233A1 Cell population with identification codes and method of screening cell population
10/09/2003CA2480751A1 Tolerogenic antigen-presenting cells
10/09/2003CA2480694A1 Ox40r binding agents
10/09/2003CA2480286A1 Disruption of the redk gene
10/09/2003CA2480263A1 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003CA2480190A1 Endothelial cells derived from human embryonic stem cells
10/09/2003CA2479903A1 Collagen biofabric and methods of preparation and use therefor
10/09/2003CA2479763A1 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350849A2 Method for cloning and expression of BsaI restriction endonuclease and Bsal methylase in E. coli
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
1 ... 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 ... 1827